blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1076697

EP1076697 - SEMAPHORIN POLYPEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.07.2009
Database last updated on 05.10.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Immunex Corporation
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[N/P]
Former [2008/33]For all designated states
IMMUNEX CORPORATION
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
Former [2001/08]For all designated states
IMMUNEX CORPORATION
51 University Street
Seattle Washington 98101 / US
Inventor(s)01 / SPRIGGS, Melanie, K.
2256 12th Avenue West
Seattle, WA 98119 / US
 [2001/08]
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
[N/P]
Former [2001/08]UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date99920356.505.05.1999
[2001/08]
WO1999US09831
Priority number, dateUS19980085497P14.05.1998         Original published format: US 85497 P
[2001/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9958676
Date:18.11.1999
Language:EN
[1999/46]
Type: A2 Application without search report 
No.:EP1076697
Date:21.02.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 18.11.1999 takes the place of the publication of the European patent application.
[2001/08]
Type: B1 Patent specification 
No.:EP1076697
Date:17.09.2008
Language:EN
[2008/38]
Search report(s)International search report - published on:EP20.01.2000
ClassificationIPC:C12N15/12, C07K14/47, A61K38/17, C07K16/18, C12N15/62
[2001/08]
CPC:
C07K14/4703 (EP,US); C07K14/4702 (EP,US); C07K16/18 (EP,US);
A61K38/00 (EP,US); C07K2319/00 (EP,US); C07K2319/30 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/08]
TitleGerman:SEMAPHORIN POLYPEPTIDE[2001/08]
English:SEMAPHORIN POLYPEPTIDES[2001/08]
French:POLYPEPTIDES DE SEMAPHORINE[2001/08]
Entry into regional phase12.12.2000National basic fee paid 
12.12.2000Designation fee(s) paid 
12.12.2000Examination fee paid 
Examination procedure08.12.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.12.2000Examination requested  [2001/08]
02.08.2004Despatch of a communication from the examining division (Time limit: M06)
14.02.2005Reply to a communication from the examining division
27.04.2006Despatch of a communication from the examining division (Time limit: M06)
07.11.2006Reply to a communication from the examining division
29.08.2007Despatch of a communication from the examining division (Time limit: M02)
31.10.2007Reply to a communication from the examining division
24.04.2008Communication of intention to grant the patent
28.07.2008Fee for grant paid
28.07.2008Fee for publishing/printing paid
Opposition(s)18.06.2009No opposition filed within time limit [2009/35]
Fees paidRenewal fee
14.05.2001Renewal fee patent year 03
14.05.2002Renewal fee patent year 04
13.05.2003Renewal fee patent year 05
13.05.2004Renewal fee patent year 06
12.05.2005Renewal fee patent year 07
23.03.2006Renewal fee patent year 08
14.05.2007Renewal fee patent year 09
28.03.2008Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT17.09.2008
BE17.09.2008
CY17.09.2008
DK17.09.2008
FI17.09.2008
NL17.09.2008
SE17.12.2008
GR18.12.2008
PT17.02.2009
IE05.05.2009
LU05.05.2009
MC31.05.2009
[2011/44]
Former [2011/25]AT17.09.2008
BE17.09.2008
DK17.09.2008
FI17.09.2008
NL17.09.2008
SE17.12.2008
GR18.12.2008
PT17.02.2009
IE05.05.2009
LU05.05.2009
MC31.05.2009
Former [2010/28]AT17.09.2008
BE17.09.2008
DK17.09.2008
FI17.09.2008
NL17.09.2008
SE17.12.2008
PT17.02.2009
IE05.05.2009
MC31.05.2009
Former [2010/19]AT17.09.2008
BE17.09.2008
DK17.09.2008
FI17.09.2008
NL17.09.2008
SE17.12.2008
PT17.02.2009
MC31.05.2009
Former [2010/06]AT17.09.2008
BE17.09.2008
DK17.09.2008
FI17.09.2008
NL17.09.2008
PT17.02.2009
MC31.05.2009
Former [2009/30]AT17.09.2008
BE17.09.2008
FI17.09.2008
NL17.09.2008
PT17.02.2009
Former [2009/19]AT17.09.2008
BE17.09.2008
FI17.09.2008
Former [2009/15]AT17.09.2008
FI17.09.2008
Cited inInternational search[PX]EP0892047  (HOECHST MARION ROUSSEL DE GMBH [DE]) [PX] 1-14,16,18-23 * 99.95% identity in a 2001 BP overlap between SEQ ID NO 1 of EP892047 and SEQ ID 1 of the application * * examples 8,9 *;
 [E]WO9945114  (ZYMOGENETICS INC [US]) [E] 1-16,19-23 * 99.75% identity in a 2001 BP overlap between SEQ ID NO 1 of WO9945114 and SEQ ID NO 1 of the application * * example 4 *;
 [PX]  - YAMADA A ET AL, "Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108", JOURNAL OF IMMUNOLOGY., THE WILLIAMS AND WILKINS CO. BALTIMORE., US, (19990401), vol. 162, ISSN 0022-1767, pages 4094 - 4100, XP002123609 [PX] 1-14,16,19-23 * 99.8% identity in 2001 BP overlap between the sequence in figure 1 and SEQ ID NO 1 * * page 40094, column 2, paragraph 2 *
 [PX]  - XU X ET AL, "Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins", JOURNAL OF BIOLOGICAL CHEMISTRY., AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD., US, (19980828), vol. 273, no. 35, ISSN 0021-9258, pages 22428 - 22434, XP002113886 [PX] 1-14,19-23 * abstract * * the sequence of sema K1 in figure 1 corresponds to seq ID NO 2 *

DOI:   http://dx.doi.org/10.1074/jbc.273.35.22428
 [PX]  - LANGE C ET AL, "New eukaryotic semaphorins with close homology to semaphorins of viruses", GENOMICS, SAN DIEGO., US, (19980801), vol. 51, ISSN 0888-7543, pages 340 - 350, XP002113887 [PX] 1-14,19-23 * abstract *

DOI:   http://dx.doi.org/10.1006/geno.1998.5256
 [XA]  - ENSSER A ET AL, "Alcephaline herpesvirus type 1 has a semaphorin-like gene", JOURNAL OF GENERAL VIROLOGY., SOCIETY FOR GENERAL MICROBIOLOGY, READING., GB, (1995), vol. 76, ISSN 0022-1317, pages 1063 - 1067, XP002113888 [X] 17 * the whole document * [A] 1
ExaminationWO9921997
    - COMEAU M.R. ET AL, "A Poxvirus-Encoded Semaphorin Induces Cytokine Production from Monocytes and Binds to a Novel Cellular Semaphorin Receptor, VESPR", IMMUNITY, (199804), vol. 8, pages 473 - 482, XP000945259

DOI:   http://dx.doi.org/10.1016/S1074-7613(00)80552-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.